Registration - In-house Corporation

Vertex Pharmaceuticals (Canada) Incorporated / Michael Siauw, General Manager – Canada

Registration Information

In-house Corporation name: Vertex Pharmaceuticals (Canada) Incorporated
Responsible Officer Name: Michael Siauw, General Manager – Canada
Initial registration start date: 2020-03-18
Registration status: Active
Registration Number: 945696-366162

Associated Communications

Monthly communication reports in the last 6 months: 8

View all monthly communication reports: 41

Version 1 of 8 (2020-03-18 to 2020-07-10)

Registration versions:

Version 1 of 8 (2020-03-18 to 2020-07-10)

Lobbying Information

Subject Matters

Economic Development
Health
Intellectual Property
International Trade
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disorder and orphan drug policies
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.

Regulation

Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board

Communication Techniques

Written communication
Oral communication

Government Institutions

Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

In-house Corporation Details

Description of activities

Vertex is a global biotechnology company that discovers, develops and commercializes innovative medicines. We strive to improve the lives of patients suffering from rare disorders and are currently investing in multiple ongoing research programs targeting serious and life-threatening diseases.

Responsible officer name and position during the period of this registration

Michael Siauw, Michael Siauw

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
20 Bay Street
unit 1520
Toronto, ON M5J 2N8
Canada

Telephone number: 647-790-1602

Parent Company Information

Vertex Pharmaceuticals Incorporated
- 50 Northern Avenue
  Boston, MA 02210
  United States of America

Subsidiary Beneficiary Information

Vertex Pharmaceuticals (Canada) Incorporated does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Christina Cunningham, Director, Public Affairs | No public offices held
Michael Siauw, Michael Siauw | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Vertex Pharmaceuticals (Canada) Incorporated

The following names have been used on or after July 2, 2008

Name	From	To
Vertex Pharmaceuticals (Canada) Incorporated	2020-03-18	current

Vertex Pharmaceuticals (Canada) Incorporated

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2026-06-11

Search and menus

Language selection

Registration - In-house Corporation

Vertex Pharmaceuticals (Canada) Incorporated / Michael Siauw, General Manager – Canada

Registration Information

Associated Communications

Version 1 of 8 (2020-03-18 to 2020-07-10)

Version 1 of 8 (2020-03-18 to 2020-07-10)

Subject Matters

Subject Matter Details

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties